CRIS Current Research Information System

BARBARO, MARIA RAFFAELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.392
NA - Nord America 2.983
EU - Europa 2.951
AF - Africa 302
SA - Sud America 195
OC - Oceania 19
Totale 9.842
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.930
IT - Italia 1.453
SG - Singapore 930
CN - Cina 835
VN - Vietnam 779
GB - Regno Unito 323
HK - Hong Kong 323
DE - Germania 242
SE - Svezia 205
IN - India 158
BR - Brasile 140
FR - Francia 140
NL - Olanda 118
KR - Corea 105
RU - Federazione Russa 105
IE - Irlanda 75
TG - Togo 74
CI - Costa d'Avorio 73
FI - Finlandia 60
ZA - Sudafrica 59
JP - Giappone 56
CH - Svizzera 38
BE - Belgio 28
CD - Congo 27
NG - Nigeria 26
CA - Canada 24
EE - Estonia 24
PH - Filippine 24
UA - Ucraina 24
AT - Austria 23
ID - Indonesia 23
AR - Argentina 22
JO - Giordania 21
SC - Seychelles 21
TH - Thailandia 20
BD - Bangladesh 18
BG - Bulgaria 18
TR - Turchia 17
ES - Italia 16
AU - Australia 15
EC - Ecuador 14
TW - Taiwan 14
IR - Iran 13
MX - Messico 13
AL - Albania 10
PL - Polonia 9
PT - Portogallo 9
CO - Colombia 8
IQ - Iraq 7
PK - Pakistan 7
EG - Egitto 6
CZ - Repubblica Ceca 5
HR - Croazia 5
MY - Malesia 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
CL - Cile 4
DK - Danimarca 4
KZ - Kazakistan 4
LT - Lituania 4
MA - Marocco 4
NP - Nepal 4
NZ - Nuova Zelanda 4
KE - Kenya 3
KG - Kirghizistan 3
LV - Lettonia 3
PY - Paraguay 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
YE - Yemen 3
AG - Antigua e Barbuda 2
BB - Barbados 2
BY - Bielorussia 2
CR - Costa Rica 2
GR - Grecia 2
IL - Israele 2
NI - Nicaragua 2
OM - Oman 2
RO - Romania 2
TN - Tunisia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
HN - Honduras 1
JM - Giamaica 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MT - Malta 1
PA - Panama 1
Totale 9.836
Salva come PNG Salva come JPEG
Città #
Singapore 676
Ashburn 317
Hong Kong 293
Bologna 279
Fairfield 249
Southend 241
Hefei 208
Ho Chi Minh City 198
Hanoi 181
San Jose 168
Chandler 149
Santa Clara 145
Milan 137
Woodbridge 125
Seattle 111
Houston 109
Wilmington 109
Seoul 96
Rome 91
Cambridge 90
Beijing 89
Boardman 81
Los Angeles 77
Lomé 74
Abidjan 73
Dublin 73
Brescia 71
Princeton 70
Ann Arbor 69
Frankfurt am Main 60
Dong Ket 54
Florence 54
Lauterbourg 50
Council Bluffs 49
Tokyo 46
New York 42
Helsinki 38
Munich 35
Nanjing 35
Naples 32
Da Nang 30
Padova 30
Johannesburg 29
Haiphong 28
Dallas 27
Lubumbashi 26
Parma 26
Turin 26
Westminster 26
Berlin 24
Orem 24
Bengaluru 23
Redondo Beach 23
São Paulo 23
Abeokuta 22
Amsterdam 22
Bern 21
Amman 20
San Diego 20
Shanghai 18
Buffalo 17
Changsha 17
London 17
Brussels 16
Nuremberg 16
Lappeenranta 15
Pisa 15
Sofia 15
Guangzhou 14
Hyderabad 14
Jakarta 14
Redmond 14
Denver 13
Vienna 13
Beerse 12
Chicago 12
Falls Church 12
Saint Petersburg 12
Ardabil 10
Jinan 10
Nanchang 10
Padua 10
Pomigliano d'Arco 10
Poplar 10
The Dalles 10
Thái Nguyên 10
Verona 10
Modena 9
Montreal 9
Phoenix 9
Pune 9
Ravenna 9
Tirana 9
Ascoli Piceno 8
Bangkok 8
Biên Hòa 8
Can Tho 8
Des Moines 8
Hải Dương 8
Lausanne 8
Totale 6.090
Salva come PNG Salva come JPEG
Nome #
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 342
5-oxoETE triggers nociception in constipation-predominant irritable bowel syndrome through MAS-related G protein–coupled receptor D 319
Escherichia coli Nissle 1917 restores epithelial permeability alterations induced by irritable bowel syndrome mediators 312
Management of Irritable Bowel Syndrome With Diarrhea 309
METODO E KIT PER LA DIAGNOSI DELLA SENSIBILITA’ AL GLUTINE NON ASSOCIATA ALLA CELIACHIA 280
Collinsella aerofaciens as a predictive marker of response to probiotic treatment in non-constipated irritable bowel syndrome 274
Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome 235
Advancements in drug development for diarrhea-predominant irritable bowel syndrome 229
Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome 223
New insights into irritable bowel syndrome pathophysiological mechanisms: contribution of epigenetics 221
Lactiplantibacillus plantarum (CECT7484 and CECT7485) and Pedioccoccus acidilactici (CECT7483) enhance actin cytoskeleton and CYP1A1 expression restoring epithelial permeability alterations induced by irritable bowel syndrome mediators 220
Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial 212
Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier 205
Serum zonulin and its diagnostic performance in non-coeliac gluten sensitivity 200
Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease 197
Neuroprotection of microglial conditioned medium on 6-hydroxydopamine-induced neuronal death: role of transforming growth factor beta2 197
Colonic immune cells in irritable bowel syndrome: A systematic review and meta-analysis 196
Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS 189
Elucidating the gut microbiome of ulcerative colitis: bifidobacteria as novel microbial biomarkers 188
Diagnostic challenges of symptomatic uncomplicated diverticular disease 187
Non-celiac gluten sensitivity in the context of functional gastrointestinal disorders 186
Pathophysiology of Diverticular Disease: From Diverticula Formation to Symptom Generation 181
Interferon-γ is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism 179
null 179
Molecular Mechanisms Underlying Loss of Vascular and Epithelial Integrity in Irritable Bowel Syndrome 177
Fecal Clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome 177
Post COVID-19 irritable bowel syndrome 175
Nerve fiber overgrowth in patients with symptomatic diverticular disease 167
Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome. 156
Supernatants of irritable bowel syndrome mucosal biopsies impair human colonic smooth muscle contractility 155
Pathophysiology and Clinical Management of Bile Acid Diarrhea 154
Chronic constipation: from pathophysiology to management 152
Current and Novel Therapies for Eosinophilic Gastrointestinal Diseases 152
Consumption of 2 Green Kiwifruits Daily Improves Constipation and Abdominal Comfort - Results of an International Multicenter Randomized Controlled Trial 149
The Role of Microbiota in Upper Gastrointestinal Cancers 146
Meta-analysis: Post-COVID-19 functional dyspepsia and irritable bowel syndrome 143
Implications of SARS-CoV-2 infection for neurogastroenterology 143
Treatment of diverticular disease with aminosalicylates: The evidence 142
Cytochromes b561: ascorbate-mediated trans-membrane electron transport 141
The role of microbiota and its modulation in colonic diverticular disease 140
Corrigendum: Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier (Front. Nutr., (2021), 8, (718356), 10.3389/fnut.2021.718356) 140
Microbiota modulation in disorders of gut-brain interaction 134
Recent advances in understanding non-celiac gluten sensitivity 134
Fecal short-chain fatty acids in non-constipated irritable bowel syndrome: a potential clinically relevant stratification factor based on catabotyping analysis 129
µ-opioid receptor, β-endorphin, and cannabinoid receptor-2 are increased in the colonic mucosa of irritable bowel syndrome patients. 128
Protease-activated receptor 1 is implicated in irritable bowel syndrome mediators-induced signaling to thoracic human sensory neurons 126
AIR12, a b-type cytochrome of the plasma membrane of Arabidopsis thaliana is a negative regulator of resistance against Botrytis cinerea 114
Gut microbiota signatures and modulation in irritable bowel syndrome 112
Pre- and probiotic overview 112
null 101
Impact of the Trophic Effects of the Secretome from a Multistrain Probiotic Preparation on the Intestinal Epithelia 94
Digestive symptoms in daily life of chronic adrenal insufficiency patients are similar to irritable bowel syndrome symptoms 87
Role of inflammation in pediatric irritable bowel syndrome 86
Italian nationwide survey of pharmacologic treatments in diverticular disease: Results from the REMAD registry 85
null 81
Letter: Post-COVID-19 disorders of gut–brain interaction (DGBI)—just post-infectious or a multifaceted entity? Authors' reply 80
Long-Term Impact of COVID-19 on Disorders of Gut–Brain Interaction: Incidence, Symptom Burden, and Psychological Comorbidities 75
Letter: Post-COVID-19 functional dyspepsia and irritable bowel syndrome—Authors' reply 65
Functional Foods and Nutraceuticals in Irritable Bowel Syndrome 61
A Probiotic Mixture of Lactobacillus rhamnosus LR 32, Bifidobacterium lactis BL 04, and Bifidobacterium longum BB 536 Counteracts the Increase in Permeability Induced by the Mucosal Mediators of Irritable Bowel Syndrome by Acting on Zonula Occludens 1 52
Multistrain Probiotics Plus Vitamin D Improve Gut Barrier Function and Gut Microbiota Composition in Irritable Bowel Syndrome Without Constipation: Results from a Double-Blind, Randomized, Placebo-Controlled Trial 47
Psychological and Clinical Factors Mediate Post-COVID-19 Irritable Bowel Syndrome 38
Therapeutic Role of Probiotics for the Treatment of Dyspepsia: A Review of the Literature 33
Totale 10.043
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.200
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.200
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021213 0 0 0 0 0 0 0 0 0 64 35 114
2021/2022882 70 44 17 36 75 47 44 44 53 24 325 103
2022/20231.053 79 216 75 83 79 84 34 91 157 24 67 64
2023/2024594 21 60 40 57 70 69 23 30 30 86 64 44
2024/20252.109 116 266 190 203 275 104 148 127 75 140 158 307
2025/20263.849 310 381 332 338 361 219 637 190 839 242 0 0
Totale 10.043